Uncategorized

As primary rates go, so goes relative value

admin | April 23, 2021

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

With MBS spreads near the tightest levels in market history, small differences across sectors have a bigger impact on relative value. One set of differences includes effective primary market rates. Conventional conforming loans and FHA and VA loans all get different rates. So do nonconforming jumbo loans. Lately, VA rates have run noticeably low, and nonconforming jumbo rates noticeably high. All else equal, relative value lines up the same way.

The average rate received by a mortgage borrower has fallen almost every month since the start of 2019 (Exhibit 1). This is reflected in the average rate on conforming balance loans sold into Fannie Mae, Freddie Mac, and Ginnie Mae pools and grouped by the month of origination. This approach is more accurate than rate surveys, and the major surveys do not include data on VA loans. The disadvantage in origination data is delay, since there are lags between rate lock, closing, and pooling. The market can only track data on loans originated through March, and those data do not yet reflect the full impact of higher rates in February and March 2021.

Exhibit 1: Mortgage rates have fallen steadily since the start of 2019

Note: Conforming balance loans only. GSE loans include only owner-occupied loans. Data on loans originated through March 2021.
Source: Fannie Mae, Freddie Mac, Ginnie Mae, Amherst Pierpont Securities

VA borrowers typically receive a much lower rate than conventional borrowers (Exhibit 2). This is mostly due to the guarantee fee difference between Ginnie Mae and the GSEs. Ginnie Mae does not buy the credit risk of loans sold into pools. They expect all servicers to remit the required principal and interest each month for loans in Ginnie Mae MBS, even for loans that have stopped paying. A servicer that fails to do so is in default, and only then would Ginnie Mae need to advance the missing principal and interest to the MBS. Since all Ginnie Mae loans are insured or guaranteed by another government entity, the Ginnie Mae guarantee fee is very small. The GSEs, which do bear the direct risk of borrower default, need to charge a much higher amount. On average the guarantee fee difference can exceed 50 bp, and much of that difference is captured by VA borrowers.

Exhibit 2: VA borrowers typically receive much lower rates than conventional borrowers

Source: Fannie Mae, Freddie Mac, Ginnie Mae, Amherst Pierpont Securities

FHA rates are typically higher than VA rates, even though they can be sold into the same MBS security. Lenders often place credit overlays on FHA borrowers, reflecting higher FHA default rates; lenders face some costs when loans default. Both FHA and VA rates increased relative to conventional rates after 2017 and the spread between FHA and conventional mortgages was typically within ±10 bp.

Spreads on FHA and VA loans compared to conventional loans have widened since late 2020. This means government rates were falling faster than conventional rates at the end of the year and may indicate that government rates have not increased as much as conventional rates over the last few months. As a result, Ginnie Mae speeds may not fall as much as conventional speeds. Data from the MBS’s weekly applications survey backs this up. The survey shows the conventional refinance index has fallen more than the government refinance index since January, and that FHA rates have been lower than conventional rates for most of 2021.

A similar trend can be seen in agency-eligible and agency-ineligible jumbo loans (Exhibit 3). Rates for these loans usually are calculated relative to conforming balance conventional loans. The spread for conforming jumbo loans is typically close to zero, while FHA and especially VA jumbo loans still receive lower rates. Spreads for FHA and VA jumbo loans widened to the conventional benchmark similarly to their conforming balance loans.

Exhibit 3: FHA, VA, and non-conforming jumbo spreads are also falling

Source: Fannie Mae, Freddie Mac, Ginnie Mae, Bankrate, Amherst Pierpont Securities

Bankrate estimates the rate for jumbo loans that are too large for agency MBS. Typically, these loans received higher rates than agency-eligible loans, although from mid-2017 through mid-2019 the jumbo rate fell below the average conforming rate. This coincided with a big increase in private-label securitizations. However, PLS issuance dried up during the early months of the Covid-19 pandemic, sending spreads higher. Spreads appear to have fallen in the second half of 2020 and into 2021, which suggests that jumbo rates may not have increased as much as conventional rates in 2021.

The most watched indicators of 30-year mortgage rates track conventional mortgages. However, rates for alternate products like FHA, VA, and jumbo loans do not always move in unison with conventional rate. Unfortunately, it can be difficult to get a real-time view of the prevailing mortgage rate for some products, like VA loans. Reviewing origination data can provide insight, albeit lagged, into recent origination trends and shows that originators may be putting more focus on FHA, VA, and jumbo loans.

Investors should keep differences in primary rates in mind. For the same MBS coupon and same collateral WAC, securities backed by VA loans may have a higher refinancing incentive than other collateral. FHA and conventional conforming loans may have an incentive somewhere in the middle. And jumbo nonconforming loans may have the lowest. In a market with tight spreads, the resulting differences in prepayment speeds and carry can add up to something that matters.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.